trial

Effectiveness of Adherence Therapy for Schizophrenia

NCTId NCT01780116
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1, Phase 2 · Completed
Enrollment 134 (actual)
Sponsored by The Hong Kong Polytechnic University
Primary completion 2015-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1, Phase 2
Status
Completed
Enrollment
134 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2013-05
Primary completion
2015-12
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Adherence Therapy

Sponsors

The Hong Kong Polytechnic UniversityLead Sponsor
Castle Peak HospitalCollaborator
Kwai Chung HospitalCollaborator

Investigators

1
WT Chien, PhDPrincipal Investigator

Sites

2 total
Kwai Chung, Hong KongTuenmen, Hong Kong

Linked catalysts

1
Effectiveness of Adherence Therapy for Schizophrenia — primary completion2015-12

Facts & assertions

4 sourced
Enrollment
134
Phase
PHASE1,PHASE2
Primary Completion Date
2015-12
Status
COMPLETED
relationships
The graph out of here
drug
Adherence Therapy
drug
lead_sponsor
The Hong Kong Polytechnic University
company
collaborator
Castle Peak Hospital
company
Kwai Chung Hospital
company
indication
Schizophreniform Disorder
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
WT Chien, PhD
person